PRELUDE CAPITAL MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,203,244
+42.3%
67,636
+21.6%
0.08%
+90.9%
Q1 2024$845,676
+1.5%
55,600
+13.9%
0.04%
-20.0%
Q4 2023$833,504
+69.7%
48,800
-16.9%
0.06%
+71.9%
Q3 2023$491,167
+112.1%
58,752
+530.3%
0.03%
+113.3%
Q2 2023$231,558
-80.6%
9,322
-90.8%
0.02%
-76.2%
Q4 2022$1,196,332
+409.1%
101,127
+71.6%
0.06%
+687.5%
Q3 2022$235,000
-47.0%
58,927
-43.4%
0.01%
-38.5%
Q2 2022$443,000
-56.1%
104,074
-1.8%
0.01%
-55.2%
Q1 2022$1,008,000
-49.7%
105,951
+0.4%
0.03%
-43.1%
Q4 2021$2,005,000
-37.7%
105,528
+9.0%
0.05%
-37.8%
Q3 2021$3,220,000
+5451.7%
96,782
+3126.1%
0.08%
+2633.3%
Q2 2020$58,000
-74.6%
3,000
-85.4%
0.00%
-66.7%
Q4 2019$228,000
+5600.0%
20,500
+3316.7%
0.01%
Q3 2019$4,000
-50.0%
600
-33.3%
0.00%
Q2 2019$8,0000.0%900
-10.0%
0.00%
Q1 2019$8,0001,000
+1269.9%
0.00%
Q4 2018$0
-100.0%
73
-6.4%
0.00%
Q2 2018$1,000
-99.2%
78
-99.3%
0.00%
-100.0%
Q3 2014$126,000
-20.8%
11,807
-30.2%
0.02%
-18.2%
Q2 2014$159,000
+8.9%
16,925
-20.2%
0.02%
+15.8%
Q1 2014$146,00021,2050.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders